We are live on
!
Find out more
Cambridge Investment Research Advisors Portfolio holdings
AUM
$44.6B
1-Year Est. Return
28.94%
This Fund
S&P 500
This Quarter
Est. Return
+1.37%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$11.4B
AUM Growth
+$504M
(+4.6%)
Cap. Flow
+$402M
Cap. Flow
% of AUM
3.53%
Top 10 Holdings %
Top 10 Hldgs %
17.81%
Holding
2,458
New
259
Increased
1,134
Reduced
877
Closed
119
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$23.1M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$23.1M |
| 3 |
First Trust Enhanced Short Maturity ETF
FTSM
|
+$19M |
| 4 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$15.7M |
| 5 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$15.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$28M |
| 2 |
First Trust Smith Unconstrained Bond ETF
UCON
|
+$23.9M |
| 3 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$18.3M |
| 4 |
First Trust Smith Opportunistic Fixed Income ETF
FIXD
|
+$9.64M |
| 5 |
Vanguard Total International Stock ETF
VXUS
|
+$8.31M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.41% |
| 2 | Financials | 4.96% |
| 3 | Healthcare | 3.93% |
| 4 | Consumer Discretionary | 3.62% |
| 5 | Industrials | 3.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1151
Opko Health
OPK
$1.04B
| $865K | 0.01% |
413,828
-5,714
| -1% | -$11.7K |
|
|
EVF
1152
Eaton Vance Senior Income Trust
EVF
$91.2M
| $864K | 0.01% |
141,097
+3,034
| +2% | +$18.8K |
|
|
ETB
1153
Eaton Vance Tax-Managed Buy-Write Income Fund
ETB
$460M
| $863K | 0.01% |
55,129
-85
| -0.2% | -$1.33K |
|
|
INCE
1154
Franklin Income Equity Focus ETF
INCE
$279M
| $862K | 0.01% |
23,556
+16,695
| +243% | +$606K |
|
1155
Energizer
ENR
$1.56B
| $860K | 0.01% |
19,742
-131
| -0.7% | -$5.21K |
|
1156
BlackRock Enhanced Captial and Income Fund
CII
$1.01B
| $859K | 0.01% |
53,147
+17,675
| +50% | +$280K |
|
|
CSII
1157
DELISTED
Cardiovascular Systems, Inc.
CSII
| $858K | 0.01% |
18,065
+2,615
| +17% | +$123K |
|
1158
Galectin Therapeutics
GALT
$317M
| $857K | 0.01% |
233,644
+1,090
| +0.5% | +$3.94K |
|
1159
AMC Entertainment Holdings
AMC
$2.35B
| $855K | 0.01% |
7,991
+169
| +2% | +$18.4K |
|
1160
Sony
SONY
$138B
| $855K | 0.01% |
72,335
-2,185
| -3% | -$24.7K |
|
1161
Global X Alternative Income ETF
ALTY
$45.8M
| $854K | 0.01% |
57,074
+2,816
| +5% | +$41.9K |
|
1162
Invesco DB Oil Fund
DBO
$387M
| $854K | 0.01% |
90,254
-7,429
| -8% | -$72.8K |
|
1163
Jacobs Solutions
J
$17B
| $854K | 0.01% |
11,288
-3,407
| -23% | -$244K |
|
1164
Halliburton
HAL
$27.7B
| $852K | 0.01% |
45,210
+10,055
| +29% | +$208K |
|
1165
Global X MLP & Energy Infrastructure ETF
MLPX
$3.56B
| $850K | 0.01% |
23,038
-76,359
| -77% | -$2.84M |
|
1166
Nuveen ESG Large-Cap Value ETF
NULV
$2.29B
| $849K | 0.01% |
27,169
+6,966
| +34% | +$212K |
|
1167
Textron
TXT
$15.3B
| $849K | 0.01% |
17,343
+1,449
| +9% | +$70.7K |
|
1168
CMS Energy
CMS
$22B
| $845K | 0.01% |
13,215
-700
| -5% | -$42.5K |
|
1169
iShares MSCI Hong Kong ETF
EWH
$1.21B
| $843K | 0.01% |
37,125
+7,356
| +25% | +$179K |
|
1170
Sabra Healthcare REIT
SBRA
$5.15B
| $842K | 0.01% |
36,682
+2,890
| +9% | +$61.6K |
|
1171
iShares Micro-Cap ETF
IWC
$1.5B
| $841K | 0.01% |
9,541
-2,117
| -18% | -$190K |
|
1172
Sprott Physical Silver Trust
PSLV
$13.3B
| $839K | 0.01% |
134,456
+2,920
| +2% | +$18.3K |
|
|
EVG
1173
Eaton Vance Short Duration Diversified Income Fund
EVG
$144M
| $838K | 0.01% |
64,392
+143
| +0.2% | +$1.9K |
|
1174
BlackRock Enhanced Global Dividend Trust
BOE
$695M
| $837K | 0.01% |
80,226
-12,647
| -14% | -$132K |
|
|
KSU
1175
DELISTED
Kansas City Southern
KSU
| $836K | 0.01% |
6,284
-2,269
| -27% | -$283K |
|
Similar funds
LP
HF
RIM
Cambridge Investment Research Advisors's Q3 2019 Portfolio in Review
As of Q3 2019, Cambridge Investment Research Advisors held 2,458 positions worth $11.4B, up 4.6% from $10.9B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Cambridge Investment Research Advisors deployed $402M of net new capital in Q3 2019, opening 259 new positions and adding to 1,134 existing holdings. Its largest new stake was Invesco S&P Ultra Dividend Revenue ETF: 309,094 shares worth $11.7M.
By sector, the portfolio is most concentrated in Technology at 6.4% of assets, up from 6.2% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Vanguard Short-Term Treasury ETF, an estimated $28M trimmed.
- Cambridge Investment Research Advisors's largest Q3 2019 buy was Invesco S&P Ultra Dividend Revenue ETF: 309,094 shares worth $11.7M.
- Cambridge Investment Research Advisors added most to iShares 7-10 Year Treasury Bond ETF in Q3 2019, an estimated $23.1M increase.
- Cambridge Investment Research Advisors's biggest Q3 2019 reduction was Vanguard Short-Term Treasury ETF, cutting an estimated $28M.
- Cambridge Investment Research Advisors fully exited DXC Technology in Q3 2019, selling an estimated $3.71M.
- Cambridge Investment Research Advisors's ten largest holdings make up 18% of its $11.4B portfolio in Q3 2019.
- Cambridge Investment Research Advisors opened 259 new positions and closed 119 in Q3 2019.
- Cambridge Investment Research Advisors's portfolio value rose 4.6% quarter-over-quarter to $11.4B.
Based on Cambridge Investment Research Advisors's 13F filing for Q3 2019, filed 28 Oct 2019.